OpCo 13F-HR changes
How operating companies’ stock holdings changed last quarter: a new stake, weight up, weight down, still held or closed. These are strategic stakes, not trades. Latest holdings are on OpCo 13F-HR.
Narrative
Newest filed first
| Ticker | Narrative | Company | Δ weight | Detail | Period |
|---|---|---|---|---|---|
| 26 Oct 1 | |||||
| CBRS | Weight up | Johnson & Johnson | +1.52% | +140.1% sh | Q2→Q3 |
| 13 Aug 4 | |||||
| QTTB | Closed | Pfizer | −0.31% | was 0.31% | Q1→Q2 |
| ORIC | Weight down | Pfizer | −22.06% | −92.2% sh | Q1→Q2 |
| ZURA | Weight down | Pfizer | −5.36% | −81.0% sh | Q1→Q2 |
| NXTC | Still held | Pfizer | −0.60% | kept at 0.04% | Q1→Q2 |
| 7 Aug 6 | |||||
| TRDA | New stake | Merck & Co | +2.43% | opened 2.4% | Q1→Q2 |
| STRO | New stake | Merck & Co | +1.72% | opened 1.7% | Q1→Q2 |
| Evaxion Biotech A/s | New stake | Merck & Co | +0.71% | opened 0.71% | Q1→Q2 |
| TRDA | Closed | Merck & Co | −6.28% | was 6.3% | Q1→Q2 |
| Sutro Biopharma | Closed | Merck & Co | −1.94% | was 1.9% | Q1→Q2 |
| Evaxion Biotech A/s | Closed | Merck & Co | −1.29% | was 1.3% | Q1→Q2 |
| 3 Aug 2 | |||||
| ACLX | Closed | Gilead Sciences | −36.44% | was 36.4% | Q1→Q2 |
| ASMB | Weight up | Gilead Sciences | +2.39% | +10.5% sh | Q1→Q2 |
Changes are worked out the same way as on Activity. “Still held” means the stake was kept and its weight moved less than 1%. What the featured managers bought and sold is on Activity. Not investment advice.